Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Vaccine. 2013 Aug 12;31(42):4795–4801. doi: 10.1016/j.vaccine.2013.07.085

Fig. 4.

Fig. 4

Antibody titers against lambda chain 4 weeks post-immunization of 16-week-old (A) or 10–12-week-old (B) Ifnarko-CD46Ge mice. Single i.p. injection of 2–2.5 × 105 TCID50 of MV-lambda or MV-lambda-NAP were used for immunization. All mice (representative ELISA for the experiment with 10–12-week-old mice) injected with MVlambda-NAP had a detectable antibody response to lambda immunoglobulin at 6 months post-vaccination (C). At 6 months the antibody affinity against lambda antigen was similar for both animal groups (D). Serum samples from the 10 mice vaccinated with MV-lambda-NAP were diluted 1:100–400. The positive in ELISA sera from the MV-lambda group (7 of 10 mice) were tested in dilution 1:100.